Searching across hundreds of databases
In this study, we report the human induced pluripotent stem cell line (iPSC) HSAN5-T203 M-iPSC, generated from human dermal fibroblasts (HDF) of a woman carrying a heterozygous c.608C > T mutation in the nerve growth factor gene potentially associated with hereditary sensory and autonomic neuropathy type 5 (HSAN5). HDF were reprogrammed using transient expression of key transcription factors for pluripotency and immune evasion via transfection of synthetic mRNA and miRNA. HSAN5-T203 M-iPSC retained the disease-associated genotype c.608C > T, while maintaining a normal karyotype, showed robust and abundant expression of pluripotency-associated markers and could be differentiated into cells of all three germ layers.
Pubmed ID: 30384131 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Software for single-cell flow cytometry analysis. Its functions include management, display, manipulation, analysis and publication of the data stream produced by flow and mass cytometers.
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal targets Mouse IgG (H+L)
View all literature mentionsThis recombinant targets SSEA-4
View all literature mentionsThis recombinant targets TRA-1-60
View all literature mentionsThis polyclonal targets TAGLN/Transgelin
View all literature mentionsThis monoclonal targets HNF-3beta (H-4)
View all literature mentionsThis monoclonal targets Human SOX2
View all literature mentionsThis unknown targets Pax-6
View all literature mentionsThis monoclonal targets HSP90B1
View all literature mentionsThis monoclonal targets SSEA4
View all literature mentionsThis monoclonal targets Oct-3/4
View all literature mentionsThe SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.
scicrunch.org
